Medicines Optimisation
UK/PHP/13/0087May 2013
This meeting is organised and funded by Pfizer
Agenda
• Pfizer Healthy Partnerships and the Pharmacy Development Team• Medicines Optimisation definition• Patient outcomes• 2012 campaign overview and results• Medicines Optimisation future developments
• Stand out as the leadership company for pharmacy for support, knowledge and collaboration
• Demonstrate the value of pharmacy within the local and national healthcare environment
• Continue partnering to deliver positive outcomes for pharmacy and Pfizer in reputation
Pharmacy Development Team: Strategy
Medicines Optimisation - definition1
• Improving quality, value and outcomes for patients from use of their medicines
• Higher level of engagement with patients and the public• Breaking down barriers between the professions• Incorporates concordance and adherence, more sophisticated than medicines
management
Dr Keith Ridge, Chief Pharmaceutical Officer England
1. Keith Ridge; http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained, March 2013
Patient outcomes• A challenge to measure
Launched to raise awareness:• Importance of taking medicines as prescribed• Benefits to patient health• Better value for NHS• Position community pharmacists as medicines
experts• Encourage patient engagement with community
pharmacy
Medicines Optimisation Campaign (2012)
2. Medicines Optimisation poster, Pfizer data on file Sept 2012
2
Launched in two phases:• Pharmacy media and Consumer media• Print, online media, Pharmacy Show• Radio campaign• Posters• Access Pfizer
Medicines Optimisation Campaign (2012)2
2. Medicines Optimisation poster, Pfizer data on file Sept 2012
3. Regional Medicines Optimisation posters, Pfizer, data on file Sept 2012
Regional versions (England)
24medical online & print articles
12regional online
newspapers
48social media
posts
10regional radio
bulletins
3,275,481total reach
2national
consumer pieces
4. Data on file, Nov 2012
Results
• Develop a better understanding of how Medicines Optimisation can be supported by the Professional Bodies and the ABPI
• Develop a better understanding of how patient behaviour influences Medicines Optimisation
• Develop a better understanding of how Medicines Optimisation can improve patient outcomes
Medicines Optimisation future developments:
1. Keith Ridge interview, PJ online March 2013http://www.pjonline.com/news/straight_from_the_horse%E2%80%99s_mouth_%E2%80%94_medicines_optimisation_explained2. Medicines Optimisation poster (national), Sept 20123. Medicines Optimisation posters (regional), Sept 20124. Data on file, results of media campaign, Nov 2012
• Ref quoted re £300M: Evaluation of the Scale,Causes and Costs of Waste Medicines, York Health
Econimics Consortium and School of Pharmacy, University of London, Nov 2010
References
Top Related